MYELOID LEUKEMIA
Clinical trials for MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets resistant leukemia
Disease control OngoingThis early-stage trial tests a combination of two drugs, gilteritinib and momelotinib, for adults with a specific type of acute myeloid leukemia (AML) that has come back or not responded to treatment. The main goal is to find a safe dose of momelotinib when given with gilteritini…
Matched conditions: MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Can radiation spark an immune attack on leukemia?
Knowledge-focused OngoingThis early-phase study looks at how the immune system responds to leukemia tumors after low-dose radiation given as part of standard care. Ten adults with new or recurrent myeloid leukemia will have their immune responses measured. The goal is to learn whether adding immunotherap…
Matched conditions: MYELOID LEUKEMIA
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
New tool aims to improve care for older cancer patients
Knowledge-focused OngoingThis pilot study tests a new assessment tool called IA3-CP for cancer patients aged 65 and older. The tool gathers information on aging-related issues, mental health, health behaviors, and social factors to help doctors provide better, more personalized care. 35 participants are …
Matched conditions: MYELOID LEUKEMIA
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:59 UTC